Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

China · Delayed Price · Currency is CNY

56.02

-0.83 (-1.46%)

Apr 17, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Parent Company	4.40B	-	-	-	-
Tibet Haize	534.79M	-	-	-	-
Tibet Pharmaceuticals Merger	2.55B	-	-	-	-
Liaoning Hisun	548.14M	-	-	-	-
Intersegment Effect	-4.50B	-	-	-	-
Shenyang Hisun	287.23M	-	-	-	-
Sichuan Hisun Corporation Merger	530.58M	-	-	-	-
Total	4.35B	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	4.39B	3.72B	3.36B	3.02B	2.77B
China Growth	17.91%	10.92%	11.27%	8.73%	-16.71%
Total	4.39B	3.72B	3.36B	3.02B	2.77B
Total Growth	17.91%	10.92%	11.27%	8.73%	-16.71%

Source: S&P Global Market Intelligence.